Hypothemycin
Hypothemycin, a fungal polyketide, is a multikinase inhibitor with Kis of 10/70 nM, 17/38 nM, 90 nM, 900 nM/1.5 μM, and 8.4/2.4 μM for VEGFR2/VEGFR1, MEK1/MEK2, FLT-3, PDGFRβ/PDGFRα, and ERK1/ERK2, respectively. Cheap Hypothemycin on Market,...
AZD4547
Synonyms: ABSK091, AZD-4547, AZD 4547, ABSK 091, ABSK 091 AZD4547 is a potent selective inhibitor of the FGFR family with IC50 of 0.2nM, 2.5nM, and 1.8nM, respectively, for FGFR1, FGFR2, and FGFR3 in cell-free assays. AZD4547...
Mouse IgG Isotype Control Antibodies
Syd Labs provides the broadest selection of in vivo grade recombinant mouse IgG isotype controls using the variable regions (VH and VL) from the popuplar mouse hybridoma clones, MOPC21 and C1.18.4, as well as recombinant...
Human IgG Isotype Control Antibodies
Syd Labs provides the broadest selection of in vivo grade recombinant human IgG isotype controls using the variable regions (VH and VL) from the popuplar mouse hybridoma clones, MOPC21 and C1.18.4, as well as recombinant...
SARS-CoV-2 Spike RBD Monoclonal Antibody
Monoclonal SARS-CoV-2 spike antibody as the human IgG antibody positive control for serological assays for qualitative detection or semi-quantitative measurement of human IgG antibodies specific to the SARS-CoV-2 spike protein, S1 subunit in serum or...
BCMA / CD269 / TNFRSF17 Nanobodies
Multiple clones of BCMA nanobodies bind to two different epitopes of the ECD (Extracellular Domain) of the human BCMA protein. They were tested by various functional assays of ELISA, flow cytometry, and ADCC. Good for...
Protein A Beads
Conditions of optimal Protein A bead performance in applications should be determined by the end user.
Research Grade Antibody Biosimilars
Syd Labs provides a variety of cheap research grade antibody biosimilar proteins starting from $30/mg.
Terms & Conditions
Terms & Conditions Any person who uses this website, Ushelf.com or Ushelf, for any purpose is a “User”, or “you” mentioned below, of Ushelf. Before you use this website, you must carefully read and completely accept...